Measurement and cellular sources of the soluble interleukin-2 receptor in primary central nervous system lymphoma

ISSN： 1433-7398

Source： Brain Tumor Pathology, Vol.30, Iss.1, 2013-01, pp. : 34-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis in primary central nervous system lymphoma (PCNSL)

By Takeuchi Hiroaki Matsuda Ken Kitai Ryuhei Sato Kazufumi Kubota Toshihiko

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic delay in primary central nervous system lymphoma

By Haldorsen Ingfrid S. Espeland Ansgar Larsen John Ludvig Mella Olav

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 728-734

Informa Healthcare

Access to resources Recommend Favorite

Expression of survivin, platelet-derived growth factor A (PDGF-A) and PDGF receptor α in primary central nervous system lymphoma

By Karabatsou K. Pal P. Dodd S. Haylock B. Aguirreburualde M. Moxam N. Pinson-Ellis W. Broome J. Rainov N.G.

Journal of Neuro-Oncology, Vol. 79, Iss. 2, 2006-09 ,pp. : 171-179

Springer Publishing Company

Access to resources Recommend Favorite

Primary Central Nervous System Lymphoma: Treatment with Chemotherapy and Radiotherapy

By Sarazin M. Ameri A. Monjour A. Nibio A. Poisson M. Delattre J.Y.

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2003-2007

Elsevier

Access to resources Recommend Favorite

Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma

By Basso U. Brandes A.A.

European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. : 1298-1312

Elsevier

Access to resources Recommend Favorite